Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report.

Cardiovasc Diabetol · 2014 · PMC3909938 · PMID 24423092

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Discussion In this study, we found that glimepiride significantly suppressed the plasma levels of eotaxin, FGF-2 and toxic AGE, and showed a trend to reduce those of fractalkine, sCD40L, MIP-β, VEGF and sRAGE, and to increase the levels of G-CSF and GM-CSF.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.